nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicotine—ulcerative colitis—Crohn's disease	0.568	1	CtDrD
Nicotine—SLC22A4—Crohn's disease	0.193	0.571	CbGaD
Nicotine—SLC22A5—Crohn's disease	0.145	0.429	CbGaD
Nicotine—CHAT—enteric nervous system—Crohn's disease	0.0126	0.324	CbGeAlD
Nicotine—CHAT—myenteric nerve plexus—Crohn's disease	0.00954	0.245	CbGeAlD
Nicotine—CHRNA9—mammalian vulva—Crohn's disease	0.00179	0.0461	CbGeAlD
Nicotine—Gastrointestinal discomfort—Azathioprine—Crohn's disease	0.00153	0.0507	CcSEcCtD
Nicotine—CHRNA6—skin of body—Crohn's disease	0.00109	0.028	CbGeAlD
Nicotine—Water retention—Prednisone—Crohn's disease	0.000739	0.0244	CcSEcCtD
Nicotine—CHAT—lymphoid tissue—Crohn's disease	0.000732	0.0188	CbGeAlD
Nicotine—CHAT—digestive system—Crohn's disease	0.000723	0.0186	CbGeAlD
Nicotine—CHRNA10—lymphoid tissue—Crohn's disease	0.000704	0.0181	CbGeAlD
Nicotine—CHRNA5—lymph node—Crohn's disease	0.000656	0.0169	CbGeAlD
Nicotine—CHRNB2—smooth muscle tissue—Crohn's disease	0.000633	0.0163	CbGeAlD
Nicotine—CHRNA3—skin of body—Crohn's disease	0.000606	0.0156	CbGeAlD
Nicotine—Local reaction—Mesalazine—Crohn's disease	0.000573	0.0189	CcSEcCtD
Nicotine—SLC22A3—mouth—Crohn's disease	0.00057	0.0147	CbGeAlD
Nicotine—CHRNB2—mammalian vulva—Crohn's disease	0.00057	0.0146	CbGeAlD
Nicotine—Mouth ulceration—Mercaptopurine—Crohn's disease	0.000528	0.0175	CcSEcCtD
Nicotine—CHRNA3—lymphoid tissue—Crohn's disease	0.000491	0.0126	CbGeAlD
Nicotine—Pharyngolaryngeal pain—Mesalazine—Crohn's disease	0.00047	0.0155	CcSEcCtD
Nicotine—Laryngeal pain—Mesalazine—Crohn's disease	0.000465	0.0154	CcSEcCtD
Nicotine—Burning sensation—Mesalazine—Crohn's disease	0.000457	0.0151	CcSEcCtD
Nicotine—Blister—Mesalazine—Crohn's disease	0.00044	0.0145	CcSEcCtD
Nicotine—Tongue disorder—Mesalazine—Crohn's disease	0.000436	0.0144	CcSEcCtD
Nicotine—Withdrawal syndrome—Prednisone—Crohn's disease	0.000402	0.0133	CcSEcCtD
Nicotine—CHRNA10—lymph node—Crohn's disease	0.000397	0.0102	CbGeAlD
Nicotine—CHRNA7—skin of body—Crohn's disease	0.000396	0.0102	CbGeAlD
Nicotine—Rhinorrhoea—Mesalazine—Crohn's disease	0.000392	0.0129	CcSEcCtD
Nicotine—Acne—Mesalazine—Crohn's disease	0.000377	0.0125	CcSEcCtD
Nicotine—SLC22A2—digestive system—Crohn's disease	0.000374	0.00961	CbGeAlD
Nicotine—CYP1A1—mouth—Crohn's disease	0.00037	0.00952	CbGeAlD
Nicotine—Tenderness—Mesalazine—Crohn's disease	0.000364	0.012	CcSEcCtD
Nicotine—Dysmenorrhoea—Mesalazine—Crohn's disease	0.000349	0.0115	CcSEcCtD
Nicotine—SLC22A3—smooth muscle tissue—Crohn's disease	0.00032	0.00821	CbGeAlD
Nicotine—Stomatitis—Mercaptopurine—Crohn's disease	0.000319	0.0105	CcSEcCtD
Nicotine—CHRNA7—digestive system—Crohn's disease	0.000317	0.00814	CbGeAlD
Nicotine—Abnormal dreams—Mesalazine—Crohn's disease	0.000313	0.0104	CcSEcCtD
Nicotine—CHRNA4—digestive system—Crohn's disease	0.000312	0.00803	CbGeAlD
Nicotine—Eructation—Mesalazine—Crohn's disease	0.000312	0.0103	CcSEcCtD
Nicotine—Cystitis noninfective—Mesalazine—Crohn's disease	0.00031	0.0102	CcSEcCtD
Nicotine—Influenza like illness—Mesalazine—Crohn's disease	0.000308	0.0102	CcSEcCtD
Nicotine—Cystitis—Mesalazine—Crohn's disease	0.000306	0.0101	CcSEcCtD
Nicotine—Cramps of lower extremities—Mesalazine—Crohn's disease	0.000291	0.00963	CcSEcCtD
Nicotine—SLC22A3—mammalian vulva—Crohn's disease	0.000288	0.00739	CbGeAlD
Nicotine—Mouth ulceration—Mesalazine—Crohn's disease	0.000287	0.00948	CcSEcCtD
Nicotine—Bladder pain—Mesalazine—Crohn's disease	0.000287	0.00948	CcSEcCtD
Nicotine—CHRNB2—lymph node—Crohn's disease	0.000285	0.00734	CbGeAlD
Nicotine—SLC22A4—digestive system—Crohn's disease	0.000277	0.00713	CbGeAlD
Nicotine—CHRNA3—lymph node—Crohn's disease	0.000277	0.00712	CbGeAlD
Nicotine—Ear pain—Mesalazine—Crohn's disease	0.00027	0.00892	CcSEcCtD
Nicotine—MAOB—mammalian vulva—Crohn's disease	0.000266	0.00684	CbGeAlD
Nicotine—Immune system disorder—Mercaptopurine—Crohn's disease	0.000265	0.00876	CcSEcCtD
Nicotine—Increased appetite—Mesalazine—Crohn's disease	0.000245	0.0081	CcSEcCtD
Nicotine—Atrial fibrillation—Mesalazine—Crohn's disease	0.000243	0.00803	CcSEcCtD
Nicotine—Dermatitis bullous—Mesalazine—Crohn's disease	0.000241	0.00796	CcSEcCtD
Nicotine—Arthritis—Mesalazine—Crohn's disease	0.000237	0.00783	CcSEcCtD
Nicotine—MAOB—digestive system—Crohn's disease	0.000233	0.006	CbGeAlD
Nicotine—SLC22A5—skin of body—Crohn's disease	0.000229	0.0059	CbGeAlD
Nicotine—MAOA—mammalian vulva—Crohn's disease	0.000227	0.00584	CbGeAlD
Nicotine—Affect lability—Mesalazine—Crohn's disease	0.000227	0.00749	CcSEcCtD
Nicotine—Migraine—Mesalazine—Crohn's disease	0.000227	0.00749	CcSEcCtD
Nicotine—Mood swings—Mesalazine—Crohn's disease	0.000218	0.00721	CcSEcCtD
Nicotine—Arthralgia—Mercaptopurine—Crohn's disease	0.000218	0.00719	CcSEcCtD
Nicotine—CYP1A1—epithelium—Crohn's disease	0.000215	0.00554	CbGeAlD
Nicotine—Memory impairment—Prednisone—Crohn's disease	0.000214	0.00707	CcSEcCtD
Nicotine—Abdominal pain upper—Mesalazine—Crohn's disease	0.00021	0.00695	CcSEcCtD
Nicotine—Abdominal discomfort—Azathioprine—Crohn's disease	0.000209	0.00692	CcSEcCtD
Nicotine—Oedema—Mercaptopurine—Crohn's disease	0.000209	0.00689	CcSEcCtD
Nicotine—Nasopharyngitis—Mesalazine—Crohn's disease	0.000206	0.00681	CcSEcCtD
Nicotine—CYP1A1—skin of body—Crohn's disease	0.000205	0.00527	CbGeAlD
Nicotine—CYP2C19—digestive system—Crohn's disease	0.000203	0.00523	CbGeAlD
Nicotine—Acne—Prednisone—Crohn's disease	0.000199	0.00659	CcSEcCtD
Nicotine—MAOA—digestive system—Crohn's disease	0.000199	0.00512	CbGeAlD
Nicotine—CYP2B6—skin of body—Crohn's disease	0.000199	0.00512	CbGeAlD
Nicotine—Influenza—Mesalazine—Crohn's disease	0.000199	0.00658	CcSEcCtD
Nicotine—Dysphagia—Mesalazine—Crohn's disease	0.000199	0.00658	CcSEcCtD
Nicotine—Bronchospasm—Mesalazine—Crohn's disease	0.000196	0.00647	CcSEcCtD
Nicotine—Bronchitis—Mesalazine—Crohn's disease	0.000191	0.00633	CcSEcCtD
Nicotine—Abdominal discomfort—Mesalazine—Crohn's disease	0.000191	0.00631	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00019	0.00628	CcSEcCtD
Nicotine—CYP1A1—mammalian vulva—Crohn's disease	0.000187	0.0048	CbGeAlD
Nicotine—SLC22A5—digestive system—Crohn's disease	0.000183	0.00472	CbGeAlD
Nicotine—Weight increased—Mesalazine—Crohn's disease	0.000181	0.00599	CcSEcCtD
Nicotine—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00018	0.00595	CcSEcCtD
Nicotine—Stomatitis—Mesalazine—Crohn's disease	0.000173	0.00572	CcSEcCtD
Nicotine—Hiccups—Prednisone—Crohn's disease	0.000168	0.00555	CcSEcCtD
Nicotine—Epistaxis—Mesalazine—Crohn's disease	0.000167	0.00553	CcSEcCtD
Nicotine—Sinusitis—Mesalazine—Crohn's disease	0.000166	0.0055	CcSEcCtD
Nicotine—CYP1A2—digestive system—Crohn's disease	0.000166	0.00427	CbGeAlD
Nicotine—Body temperature increased—Mercaptopurine—Crohn's disease	0.000165	0.00545	CcSEcCtD
Nicotine—CYP1A1—digestive system—Crohn's disease	0.000164	0.00421	CbGeAlD
Nicotine—CYP2B6—lymphoid tissue—Crohn's disease	0.000161	0.00415	CbGeAlD
Nicotine—Rhinitis—Mesalazine—Crohn's disease	0.00016	0.00528	CcSEcCtD
Nicotine—Fluid retention—Prednisone—Crohn's disease	0.000159	0.00527	CcSEcCtD
Nicotine—CYP2B6—digestive system—Crohn's disease	0.000159	0.0041	CbGeAlD
Nicotine—SLC22A4—lymph node—Crohn's disease	0.000158	0.00407	CbGeAlD
Nicotine—Pharyngitis—Mesalazine—Crohn's disease	0.000158	0.00523	CcSEcCtD
Nicotine—Immune system disorder—Azathioprine—Crohn's disease	0.000158	0.00522	CcSEcCtD
Nicotine—CYP2C9—digestive system—Crohn's disease	0.000158	0.00406	CbGeAlD
Nicotine—Mediastinal disorder—Azathioprine—Crohn's disease	0.000158	0.00521	CcSEcCtD
Nicotine—Oedema peripheral—Mesalazine—Crohn's disease	0.000157	0.00519	CcSEcCtD
Nicotine—Arrhythmia—Azathioprine—Crohn's disease	0.000156	0.00516	CcSEcCtD
Nicotine—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000154	0.00508	CcSEcCtD
Nicotine—CYP2E1—lymphoid tissue—Crohn's disease	0.000151	0.00389	CbGeAlD
Nicotine—CYP2E1—digestive system—Crohn's disease	0.00015	0.00384	CbGeAlD
Nicotine—Cardiac disorder—Mesalazine—Crohn's disease	0.000148	0.00489	CcSEcCtD
Nicotine—SLC22A3—lymph node—Crohn's disease	0.000144	0.0037	CbGeAlD
Nicotine—Immune system disorder—Mesalazine—Crohn's disease	0.000144	0.00476	CcSEcCtD
Nicotine—Mediastinal disorder—Mesalazine—Crohn's disease	0.000144	0.00474	CcSEcCtD
Nicotine—Diarrhoea—Mercaptopurine—Crohn's disease	0.000143	0.00472	CcSEcCtD
Nicotine—CYP19A1—lymph node—Crohn's disease	0.000142	0.00364	CbGeAlD
Nicotine—Ill-defined disorder—Azathioprine—Crohn's disease	0.000141	0.00467	CcSEcCtD
Nicotine—Mental disorder—Mesalazine—Crohn's disease	0.00014	0.00461	CcSEcCtD
Nicotine—Erythema—Mesalazine—Crohn's disease	0.000139	0.00458	CcSEcCtD
Nicotine—Malaise—Azathioprine—Crohn's disease	0.000137	0.00454	CcSEcCtD
Nicotine—Flatulence—Mesalazine—Crohn's disease	0.000137	0.00452	CcSEcCtD
Nicotine—Tension—Mesalazine—Crohn's disease	0.000136	0.0045	CcSEcCtD
Nicotine—Dysgeusia—Mesalazine—Crohn's disease	0.000136	0.00449	CcSEcCtD
Nicotine—Nervousness—Mesalazine—Crohn's disease	0.000135	0.00445	CcSEcCtD
Nicotine—Back pain—Mesalazine—Crohn's disease	0.000134	0.00443	CcSEcCtD
Nicotine—MAOB—lymph node—Crohn's disease	0.000133	0.00343	CbGeAlD
Nicotine—Muscle spasms—Mesalazine—Crohn's disease	0.000133	0.00441	CcSEcCtD
Nicotine—Vomiting—Mercaptopurine—Crohn's disease	0.000133	0.00438	CcSEcCtD
Nicotine—Rash—Mercaptopurine—Crohn's disease	0.000131	0.00435	CcSEcCtD
Nicotine—Dermatitis—Mercaptopurine—Crohn's disease	0.000131	0.00434	CcSEcCtD
Nicotine—Tremor—Mesalazine—Crohn's disease	0.00013	0.00429	CcSEcCtD
Nicotine—Amnesia—Prednisone—Crohn's disease	0.00013	0.00429	CcSEcCtD
Nicotine—Increased appetite—Prednisone—Crohn's disease	0.00013	0.00429	CcSEcCtD
Nicotine—Myalgia—Azathioprine—Crohn's disease	0.00013	0.00428	CcSEcCtD
Nicotine—Arthralgia—Azathioprine—Crohn's disease	0.00013	0.00428	CcSEcCtD
Nicotine—Ill-defined disorder—Mesalazine—Crohn's disease	0.000129	0.00425	CcSEcCtD
Nicotine—Discomfort—Azathioprine—Crohn's disease	0.000128	0.00423	CcSEcCtD
Nicotine—Angioedema—Mesalazine—Crohn's disease	0.000127	0.00419	CcSEcCtD
Nicotine—Malaise—Mesalazine—Crohn's disease	0.000125	0.00413	CcSEcCtD
Nicotine—Cardiac failure—Prednisone—Crohn's disease	0.000125	0.00413	CcSEcCtD
Nicotine—Vertigo—Mesalazine—Crohn's disease	0.000125	0.00412	CcSEcCtD
Nicotine—Syncope—Mesalazine—Crohn's disease	0.000124	0.00411	CcSEcCtD
Nicotine—Nausea—Mercaptopurine—Crohn's disease	0.000124	0.00409	CcSEcCtD
Nicotine—Palpitations—Mesalazine—Crohn's disease	0.000123	0.00405	CcSEcCtD
Nicotine—Loss of consciousness—Mesalazine—Crohn's disease	0.000122	0.00403	CcSEcCtD
Nicotine—Cough—Mesalazine—Crohn's disease	0.000121	0.004	CcSEcCtD
Nicotine—CYP3A4—digestive system—Crohn's disease	0.00012	0.00309	CbGeAlD
Nicotine—Affect lability—Prednisone—Crohn's disease	0.00012	0.00396	CcSEcCtD
Nicotine—Hypertension—Mesalazine—Crohn's disease	0.00012	0.00396	CcSEcCtD
Nicotine—CYP2D6—digestive system—Crohn's disease	0.000118	0.00304	CbGeAlD
Nicotine—Chest pain—Mesalazine—Crohn's disease	0.000118	0.0039	CcSEcCtD
Nicotine—Myalgia—Mesalazine—Crohn's disease	0.000118	0.0039	CcSEcCtD
Nicotine—Arthralgia—Mesalazine—Crohn's disease	0.000118	0.0039	CcSEcCtD
Nicotine—Anxiety—Mesalazine—Crohn's disease	0.000118	0.00389	CcSEcCtD
Nicotine—Discomfort—Mesalazine—Crohn's disease	0.000117	0.00386	CcSEcCtD
Nicotine—Irritability—Prednisone—Crohn's disease	0.000116	0.00384	CcSEcCtD
Nicotine—Hypotension—Azathioprine—Crohn's disease	0.000116	0.00384	CcSEcCtD
Nicotine—Dry mouth—Mesalazine—Crohn's disease	0.000115	0.00382	CcSEcCtD
Nicotine—Mood swings—Prednisone—Crohn's disease	0.000115	0.00381	CcSEcCtD
Nicotine—Confusional state—Mesalazine—Crohn's disease	0.000114	0.00377	CcSEcCtD
Nicotine—MAOA—lymph node—Crohn's disease	0.000114	0.00292	CbGeAlD
Nicotine—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000113	0.00374	CcSEcCtD
Nicotine—Anaphylactic shock—Mesalazine—Crohn's disease	0.000113	0.00374	CcSEcCtD
Nicotine—Oedema—Mesalazine—Crohn's disease	0.000113	0.00374	CcSEcCtD
Nicotine—Shock—Mesalazine—Crohn's disease	0.000111	0.00368	CcSEcCtD
Nicotine—Nervous system disorder—Mesalazine—Crohn's disease	0.000111	0.00367	CcSEcCtD
Nicotine—Tachycardia—Mesalazine—Crohn's disease	0.00011	0.00365	CcSEcCtD
Nicotine—Hyperhidrosis—Mesalazine—Crohn's disease	0.000109	0.00362	CcSEcCtD
Nicotine—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000107	0.00355	CcSEcCtD
Nicotine—Hypotension—Mesalazine—Crohn's disease	0.000106	0.0035	CcSEcCtD
Nicotine—SLC22A5—lymph node—Crohn's disease	0.000105	0.00269	CbGeAlD
Nicotine—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000103	0.00341	CcSEcCtD
Nicotine—Sweating increased—Prednisone—Crohn's disease	0.000103	0.00339	CcSEcCtD
Nicotine—Feeling abnormal—Azathioprine—Crohn's disease	0.000102	0.00338	CcSEcCtD
Nicotine—Insomnia—Mesalazine—Crohn's disease	0.000102	0.00338	CcSEcCtD
Nicotine—Paraesthesia—Mesalazine—Crohn's disease	0.000102	0.00336	CcSEcCtD
Nicotine—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000102	0.00336	CcSEcCtD
Nicotine—Dyspnoea—Mesalazine—Crohn's disease	0.000101	0.00333	CcSEcCtD
Nicotine—Somnolence—Mesalazine—Crohn's disease	0.000101	0.00333	CcSEcCtD
Nicotine—Dyspepsia—Mesalazine—Crohn's disease	9.96e-05	0.00329	CcSEcCtD
Nicotine—Abdominal pain—Azathioprine—Crohn's disease	9.82e-05	0.00325	CcSEcCtD
Nicotine—Body temperature increased—Azathioprine—Crohn's disease	9.82e-05	0.00325	CcSEcCtD
Nicotine—Gastrointestinal disorder—Mesalazine—Crohn's disease	9.77e-05	0.00323	CcSEcCtD
Nicotine—Fatigue—Mesalazine—Crohn's disease	9.76e-05	0.00322	CcSEcCtD
Nicotine—Pain—Mesalazine—Crohn's disease	9.68e-05	0.0032	CcSEcCtD
Nicotine—Constipation—Mesalazine—Crohn's disease	9.68e-05	0.0032	CcSEcCtD
Nicotine—Weight increased—Prednisone—Crohn's disease	9.58e-05	0.00317	CcSEcCtD
Nicotine—CYP1A1—lymph node—Crohn's disease	9.36e-05	0.00241	CbGeAlD
Nicotine—Feeling abnormal—Mesalazine—Crohn's disease	9.33e-05	0.00308	CcSEcCtD
Nicotine—Gastrointestinal pain—Mesalazine—Crohn's disease	9.25e-05	0.00306	CcSEcCtD
Nicotine—Hypersensitivity—Azathioprine—Crohn's disease	9.15e-05	0.00303	CcSEcCtD
Nicotine—Urticaria—Mesalazine—Crohn's disease	8.99e-05	0.00297	CcSEcCtD
Nicotine—Abdominal pain—Mesalazine—Crohn's disease	8.95e-05	0.00296	CcSEcCtD
Nicotine—Body temperature increased—Mesalazine—Crohn's disease	8.95e-05	0.00296	CcSEcCtD
Nicotine—Diarrhoea—Azathioprine—Crohn's disease	8.5e-05	0.00281	CcSEcCtD
Nicotine—Hypersensitivity—Mesalazine—Crohn's disease	8.34e-05	0.00276	CcSEcCtD
Nicotine—Dizziness—Azathioprine—Crohn's disease	8.22e-05	0.00272	CcSEcCtD
Nicotine—Asthenia—Mesalazine—Crohn's disease	8.12e-05	0.00268	CcSEcCtD
Nicotine—Pruritus—Mesalazine—Crohn's disease	8.01e-05	0.00265	CcSEcCtD
Nicotine—Vomiting—Azathioprine—Crohn's disease	7.9e-05	0.00261	CcSEcCtD
Nicotine—Rash—Azathioprine—Crohn's disease	7.83e-05	0.00259	CcSEcCtD
Nicotine—Dermatitis—Azathioprine—Crohn's disease	7.83e-05	0.00259	CcSEcCtD
Nicotine—Flushing—Prednisone—Crohn's disease	7.82e-05	0.00259	CcSEcCtD
Nicotine—Headache—Azathioprine—Crohn's disease	7.78e-05	0.00257	CcSEcCtD
Nicotine—Diarrhoea—Mesalazine—Crohn's disease	7.74e-05	0.00256	CcSEcCtD
Nicotine—Immune system disorder—Prednisone—Crohn's disease	7.61e-05	0.00252	CcSEcCtD
Nicotine—Arrhythmia—Prednisone—Crohn's disease	7.53e-05	0.00249	CcSEcCtD
Nicotine—Dizziness—Mesalazine—Crohn's disease	7.48e-05	0.00247	CcSEcCtD
Nicotine—Mental disorder—Prednisone—Crohn's disease	7.38e-05	0.00244	CcSEcCtD
Nicotine—Nausea—Azathioprine—Crohn's disease	7.38e-05	0.00244	CcSEcCtD
Nicotine—Erythema—Prednisone—Crohn's disease	7.34e-05	0.00242	CcSEcCtD
Nicotine—Vomiting—Mesalazine—Crohn's disease	7.2e-05	0.00238	CcSEcCtD
Nicotine—Rash—Mesalazine—Crohn's disease	7.14e-05	0.00236	CcSEcCtD
Nicotine—Dermatitis—Mesalazine—Crohn's disease	7.13e-05	0.00236	CcSEcCtD
Nicotine—Headache—Mesalazine—Crohn's disease	7.09e-05	0.00234	CcSEcCtD
Nicotine—Ill-defined disorder—Prednisone—Crohn's disease	6.81e-05	0.00225	CcSEcCtD
Nicotine—Agitation—Prednisone—Crohn's disease	6.74e-05	0.00223	CcSEcCtD
Nicotine—Nausea—Mesalazine—Crohn's disease	6.72e-05	0.00222	CcSEcCtD
Nicotine—Angioedema—Prednisone—Crohn's disease	6.7e-05	0.00222	CcSEcCtD
Nicotine—Malaise—Prednisone—Crohn's disease	6.62e-05	0.00219	CcSEcCtD
Nicotine—Vertigo—Prednisone—Crohn's disease	6.59e-05	0.00218	CcSEcCtD
Nicotine—Syncope—Prednisone—Crohn's disease	6.58e-05	0.00217	CcSEcCtD
Nicotine—Loss of consciousness—Prednisone—Crohn's disease	6.45e-05	0.00213	CcSEcCtD
Nicotine—Convulsion—Prednisone—Crohn's disease	6.36e-05	0.0021	CcSEcCtD
Nicotine—Hypertension—Prednisone—Crohn's disease	6.33e-05	0.00209	CcSEcCtD
Nicotine—Myalgia—Prednisone—Crohn's disease	6.25e-05	0.00206	CcSEcCtD
Nicotine—Arthralgia—Prednisone—Crohn's disease	6.25e-05	0.00206	CcSEcCtD
Nicotine—Anxiety—Prednisone—Crohn's disease	6.22e-05	0.00206	CcSEcCtD
Nicotine—Discomfort—Prednisone—Crohn's disease	6.17e-05	0.00204	CcSEcCtD
Nicotine—Anaphylactic shock—Prednisone—Crohn's disease	5.99e-05	0.00198	CcSEcCtD
Nicotine—Oedema—Prednisone—Crohn's disease	5.99e-05	0.00198	CcSEcCtD
Nicotine—Shock—Prednisone—Crohn's disease	5.89e-05	0.00195	CcSEcCtD
Nicotine—Nervous system disorder—Prednisone—Crohn's disease	5.87e-05	0.00194	CcSEcCtD
Nicotine—Tachycardia—Prednisone—Crohn's disease	5.84e-05	0.00193	CcSEcCtD
Nicotine—Hyperhidrosis—Prednisone—Crohn's disease	5.79e-05	0.00191	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Prednisone—Crohn's disease	5.46e-05	0.0018	CcSEcCtD
Nicotine—Insomnia—Prednisone—Crohn's disease	5.42e-05	0.00179	CcSEcCtD
Nicotine—Paraesthesia—Prednisone—Crohn's disease	5.38e-05	0.00178	CcSEcCtD
Nicotine—Dyspepsia—Prednisone—Crohn's disease	5.27e-05	0.00174	CcSEcCtD
Nicotine—Fatigue—Prednisone—Crohn's disease	5.16e-05	0.00171	CcSEcCtD
Nicotine—Constipation—Prednisone—Crohn's disease	5.12e-05	0.00169	CcSEcCtD
Nicotine—Feeling abnormal—Prednisone—Crohn's disease	4.93e-05	0.00163	CcSEcCtD
Nicotine—SLC22A5—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	4.9e-05	0.00191	CbGpPWpGaD
Nicotine—Gastrointestinal pain—Prednisone—Crohn's disease	4.9e-05	0.00162	CcSEcCtD
Nicotine—Urticaria—Prednisone—Crohn's disease	4.76e-05	0.00157	CcSEcCtD
Nicotine—CHAT—Metabolism—MTMR3—Crohn's disease	4.74e-05	0.00185	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—PLA2G4F—Crohn's disease	4.74e-05	0.00185	CbGpPWpGaD
Nicotine—Abdominal pain—Prednisone—Crohn's disease	4.73e-05	0.00156	CcSEcCtD
Nicotine—Body temperature increased—Prednisone—Crohn's disease	4.73e-05	0.00156	CcSEcCtD
Nicotine—SLC22A1—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	4.62e-05	0.0018	CbGpPWpGaD
Nicotine—SLC22A1—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	4.62e-05	0.0018	CbGpPWpGaD
Nicotine—CHRNA4—SIDS Susceptibility Pathways—IL10—Crohn's disease	4.56e-05	0.00178	CbGpPWpGaD
Nicotine—CHRNB2—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	4.48e-05	0.00175	CbGpPWpGaD
Nicotine—Hypersensitivity—Prednisone—Crohn's disease	4.41e-05	0.00146	CcSEcCtD
Nicotine—Asthenia—Prednisone—Crohn's disease	4.3e-05	0.00142	CcSEcCtD
Nicotine—CHRNB2—SIDS Susceptibility Pathways—IL1B—Crohn's disease	4.3e-05	0.00167	CbGpPWpGaD
Nicotine—Pruritus—Prednisone—Crohn's disease	4.24e-05	0.0014	CcSEcCtD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—Crohn's disease	4.11e-05	0.0016	CbGpPWpGaD
Nicotine—Diarrhoea—Prednisone—Crohn's disease	4.1e-05	0.00135	CcSEcCtD
Nicotine—CYP2A13—Metabolism—MTMR3—Crohn's disease	4.03e-05	0.00157	CbGpPWpGaD
Nicotine—SLC22A3—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	4.01e-05	0.00156	CbGpPWpGaD
Nicotine—SLC22A3—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	4.01e-05	0.00156	CbGpPWpGaD
Nicotine—SLC22A5—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	4e-05	0.00156	CbGpPWpGaD
Nicotine—CHAT—SIDS Susceptibility Pathways—TNF—Crohn's disease	3.97e-05	0.00155	CbGpPWpGaD
Nicotine—Dizziness—Prednisone—Crohn's disease	3.96e-05	0.00131	CcSEcCtD
Nicotine—Vomiting—Prednisone—Crohn's disease	3.81e-05	0.00126	CcSEcCtD
Nicotine—Rash—Prednisone—Crohn's disease	3.78e-05	0.00125	CcSEcCtD
Nicotine—Dermatitis—Prednisone—Crohn's disease	3.77e-05	0.00125	CcSEcCtD
Nicotine—Headache—Prednisone—Crohn's disease	3.75e-05	0.00124	CcSEcCtD
Nicotine—SLC22A4—Transmembrane transport of small molecules—GCKR—Crohn's disease	3.75e-05	0.00146	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—TAB1—Crohn's disease	3.7e-05	0.00144	CbGpPWpGaD
Nicotine—CHAT—Metabolism—FADS1—Crohn's disease	3.7e-05	0.00144	CbGpPWpGaD
Nicotine—CYP2B6—Metapathway biotransformation—GPX4—Crohn's disease	3.67e-05	0.00143	CbGpPWpGaD
Nicotine—CYP1A2—Estrogen Receptor Pathway—STAT3—Crohn's disease	3.63e-05	0.00141	CbGpPWpGaD
Nicotine—CYP2E1—Metapathway biotransformation—GPX4—Crohn's disease	3.6e-05	0.0014	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	3.59e-05	0.0014	CbGpPWpGaD
Nicotine—Nausea—Prednisone—Crohn's disease	3.56e-05	0.00118	CcSEcCtD
Nicotine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—FADS1—Crohn's disease	3.54e-05	0.00138	CbGpPWpGaD
Nicotine—CHRNB4—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	3.53e-05	0.00137	CbGpPWpGaD
Nicotine—SLC22A2—SLC-mediated transmembrane transport—GCKR—Crohn's disease	3.49e-05	0.00136	CbGpPWpGaD
Nicotine—CHAT—Metabolism—GPX4—Crohn's disease	3.46e-05	0.00135	CbGpPWpGaD
Nicotine—CYP1A1—Metapathway biotransformation—GPX4—Crohn's disease	3.39e-05	0.00132	CbGpPWpGaD
Nicotine—CHRNB4—SIDS Susceptibility Pathways—IL1B—Crohn's disease	3.38e-05	0.00132	CbGpPWpGaD
Nicotine—CHAT—Metabolism—GCKR—Crohn's disease	3.34e-05	0.0013	CbGpPWpGaD
Nicotine—SLC22A4—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	3.31e-05	0.00129	CbGpPWpGaD
Nicotine—SLC22A1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	3.25e-05	0.00127	CbGpPWpGaD
Nicotine—CHAT—SIDS Susceptibility Pathways—IL6—Crohn's disease	3.21e-05	0.00125	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—FADS1—Crohn's disease	3.14e-05	0.00122	CbGpPWpGaD
Nicotine—CHRNB2—SIDS Susceptibility Pathways—TNF—Crohn's disease	3.12e-05	0.00121	CbGpPWpGaD
Nicotine—CYP2C8—Metapathway biotransformation—GPX4—Crohn's disease	3.11e-05	0.00121	CbGpPWpGaD
Nicotine—SLC22A2—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	3.08e-05	0.0012	CbGpPWpGaD
Nicotine—MAOA—SIDS Susceptibility Pathways—IL10—Crohn's disease	3.07e-05	0.00119	CbGpPWpGaD
Nicotine—CHRNA7—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	3.06e-05	0.00119	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	3.05e-05	0.00119	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—GPX4—Crohn's disease	2.94e-05	0.00115	CbGpPWpGaD
Nicotine—CHRNA7—SIDS Susceptibility Pathways—IL1B—Crohn's disease	2.94e-05	0.00114	CbGpPWpGaD
Nicotine—SLC22A1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	2.87e-05	0.00112	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—GCKR—Crohn's disease	2.84e-05	0.00111	CbGpPWpGaD
Nicotine—SLC22A3—Transmembrane transport of small molecules—GCKR—Crohn's disease	2.83e-05	0.0011	CbGpPWpGaD
Nicotine—SLC22A5—Transmembrane transport of small molecules—GCKR—Crohn's disease	2.82e-05	0.0011	CbGpPWpGaD
Nicotine—CYP2C19—Metapathway biotransformation—GPX4—Crohn's disease	2.78e-05	0.00108	CbGpPWpGaD
Nicotine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	2.77e-05	0.00108	CbGpPWpGaD
Nicotine—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	2.66e-05	0.00104	CbGpPWpGaD
Nicotine—MAOB—Metabolism—PLA2G4F—Crohn's disease	2.61e-05	0.00102	CbGpPWpGaD
Nicotine—CYP2D6—Metapathway biotransformation—GPX4—Crohn's disease	2.55e-05	0.000995	CbGpPWpGaD
Nicotine—CYP2C9—Metapathway biotransformation—GPX4—Crohn's disease	2.53e-05	0.000986	CbGpPWpGaD
Nicotine—SLC22A2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	2.52e-05	0.000981	CbGpPWpGaD
Nicotine—SLC22A2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	2.52e-05	0.000981	CbGpPWpGaD
Nicotine—CHRNB2—SIDS Susceptibility Pathways—IL6—Crohn's disease	2.52e-05	0.00098	CbGpPWpGaD
Nicotine—SLC22A3—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.5e-05	0.000974	CbGpPWpGaD
Nicotine—CHRNA4—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	2.49e-05	0.000972	CbGpPWpGaD
Nicotine—SLC22A5—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.49e-05	0.000971	CbGpPWpGaD
Nicotine—CYP1A1—Arachidonic acid metabolism—PTGS2—Crohn's disease	2.48e-05	0.000968	CbGpPWpGaD
Nicotine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	2.47e-05	0.000963	CbGpPWpGaD
Nicotine—CHRNB4—SIDS Susceptibility Pathways—TNF—Crohn's disease	2.45e-05	0.000956	CbGpPWpGaD
Nicotine—CHRNA4—SIDS Susceptibility Pathways—IL1B—Crohn's disease	2.39e-05	0.000933	CbGpPWpGaD
Nicotine—CHAT—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.39e-05	0.000931	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2.38e-05	0.000927	CbGpPWpGaD
Nicotine—SLC22A4—SLC-mediated transmembrane transport—ALB—Crohn's disease	2.35e-05	0.000915	CbGpPWpGaD
Nicotine—SLC22A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	2.35e-05	0.000914	CbGpPWpGaD
Nicotine—SLC22A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	2.35e-05	0.000914	CbGpPWpGaD
Nicotine—CYP2C8—Arachidonic acid metabolism—PTGS2—Crohn's disease	2.28e-05	0.000888	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.23e-05	0.000868	CbGpPWpGaD
Nicotine—MAOB—Metabolism—MTMR3—Crohn's disease	2.22e-05	0.000866	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—PLA2G4F—Crohn's disease	2.21e-05	0.000861	CbGpPWpGaD
Nicotine—CYP1A2—Metapathway biotransformation—GPX4—Crohn's disease	2.16e-05	0.000843	CbGpPWpGaD
Nicotine—CHRNA7—SIDS Susceptibility Pathways—TNF—Crohn's disease	2.13e-05	0.00083	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	2.13e-05	0.00083	CbGpPWpGaD
Nicotine—CHAT—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.09e-05	0.000814	CbGpPWpGaD
Nicotine—CHRNB2—Circadian rythm related genes—IL6—Crohn's disease	2.05e-05	0.0008	CbGpPWpGaD
Nicotine—CYP2C19—Arachidonic acid metabolism—PTGS2—Crohn's disease	2.03e-05	0.000792	CbGpPWpGaD
Nicotine—CHRNB4—SIDS Susceptibility Pathways—IL6—Crohn's disease	1.98e-05	0.000772	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	1.95e-05	0.000761	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—MTMR3—Crohn's disease	1.88e-05	0.000732	CbGpPWpGaD
Nicotine—CYP2C9—Arachidonic acid metabolism—PTGS2—Crohn's disease	1.85e-05	0.000723	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.81e-05	0.000705	CbGpPWpGaD
Nicotine—CYP1A1—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	1.79e-05	0.000699	CbGpPWpGaD
Nicotine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	1.79e-05	0.000699	CbGpPWpGaD
Nicotine—SLC22A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	1.77e-05	0.000691	CbGpPWpGaD
Nicotine—SLC22A3—SLC-mediated transmembrane transport—ALB—Crohn's disease	1.77e-05	0.00069	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	1.77e-05	0.000688	CbGpPWpGaD
Nicotine—SLC22A5—SLC-mediated transmembrane transport—ALB—Crohn's disease	1.76e-05	0.000688	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	1.74e-05	0.000679	CbGpPWpGaD
Nicotine—CHRNA4—SIDS Susceptibility Pathways—TNF—Crohn's disease	1.74e-05	0.000677	CbGpPWpGaD
Nicotine—MAOB—Metabolism—FADS1—Crohn's disease	1.73e-05	0.000674	CbGpPWpGaD
Nicotine—CHRNA7—SIDS Susceptibility Pathways—IL6—Crohn's disease	1.72e-05	0.00067	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	1.69e-05	0.00066	CbGpPWpGaD
Nicotine—MAOA—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	1.68e-05	0.000653	CbGpPWpGaD
Nicotine—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	1.67e-05	0.00065	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.66e-05	0.000647	CbGpPWpGaD
Nicotine—SLC22A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	1.65e-05	0.000644	CbGpPWpGaD
Nicotine—MAOA—Metabolism—PLA2G4F—Crohn's disease	1.64e-05	0.000639	CbGpPWpGaD
Nicotine—MAOB—Metabolism—GPX4—Crohn's disease	1.62e-05	0.000631	CbGpPWpGaD
Nicotine—MAOA—SIDS Susceptibility Pathways—IL1B—Crohn's disease	1.61e-05	0.000627	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—PLA2G4F—Crohn's disease	1.6e-05	0.000623	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	1.59e-05	0.000619	CbGpPWpGaD
Nicotine—CYP1A2—Arachidonic acid metabolism—PTGS2—Crohn's disease	1.58e-05	0.000617	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	1.58e-05	0.000614	CbGpPWpGaD
Nicotine—SLC22A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	1.57e-05	0.000611	CbGpPWpGaD
Nicotine—MAOB—Metabolism—GCKR—Crohn's disease	1.56e-05	0.00061	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.48e-05	0.000577	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—FADS1—Crohn's disease	1.46e-05	0.000571	CbGpPWpGaD
Nicotine—SLC22A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	1.46e-05	0.000569	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.41e-05	0.00055	CbGpPWpGaD
Nicotine—CHRNA4—SIDS Susceptibility Pathways—IL6—Crohn's disease	1.4e-05	0.000546	CbGpPWpGaD
Nicotine—MAOA—Metabolism—MTMR3—Crohn's disease	1.39e-05	0.000543	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PLA2G4F—Crohn's disease	1.39e-05	0.00054	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—GPX4—Crohn's disease	1.37e-05	0.000534	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—MTMR3—Crohn's disease	1.36e-05	0.00053	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	1.36e-05	0.000529	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.35e-05	0.000526	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—GCKR—Crohn's disease	1.32e-05	0.000516	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.32e-05	0.000515	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.29e-05	0.000504	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PLA2G4F—Crohn's disease	1.29e-05	0.000504	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PLA2G4F—Crohn's disease	1.27e-05	0.000496	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.21e-05	0.000472	CbGpPWpGaD
Nicotine—SLC22A4—Transmembrane transport of small molecules—ALB—Crohn's disease	1.19e-05	0.000465	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—MTMR3—Crohn's disease	1.18e-05	0.000459	CbGpPWpGaD
Nicotine—MAOA—SIDS Susceptibility Pathways—TNF—Crohn's disease	1.17e-05	0.000455	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.15e-05	0.00045	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.15e-05	0.00045	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	1.14e-05	0.000446	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	1.14e-05	0.000446	CbGpPWpGaD
Nicotine—SLC22A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	1.11e-05	0.000433	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—MTMR3—Crohn's disease	1.1e-05	0.000428	CbGpPWpGaD
Nicotine—MAOA—Metabolism—FADS1—Crohn's disease	1.09e-05	0.000423	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—MTMR3—Crohn's disease	1.08e-05	0.000422	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.08e-05	0.000421	CbGpPWpGaD
Nicotine—CHAT—Metabolism—ALB—Crohn's disease	1.06e-05	0.000415	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—FADS1—Crohn's disease	1.06e-05	0.000413	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.05e-05	0.00041	CbGpPWpGaD
Nicotine—SLC22A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	1.04e-05	0.000403	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PLA2G4F—Crohn's disease	1.03e-05	0.0004	CbGpPWpGaD
Nicotine—MAOA—Metabolism—GPX4—Crohn's disease	1.02e-05	0.000396	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PLA2G4F—Crohn's disease	1.01e-05	0.000392	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—GPX4—Crohn's disease	9.92e-06	0.000386	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	9.85e-06	0.000384	CbGpPWpGaD
Nicotine—MAOA—Metabolism—GCKR—Crohn's disease	9.82e-06	0.000383	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—GCKR—Crohn's disease	9.58e-06	0.000373	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PLA2G4F—Crohn's disease	9.48e-06	0.000369	CbGpPWpGaD
Nicotine—MAOA—SIDS Susceptibility Pathways—IL6—Crohn's disease	9.42e-06	0.000367	CbGpPWpGaD
Nicotine—CHAT—Metabolism—PTGS2—Crohn's disease	9.31e-06	0.000363	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—FADS1—Crohn's disease	9.18e-06	0.000358	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—ALB—Crohn's disease	9.05e-06	0.000352	CbGpPWpGaD
Nicotine—SLC22A3—Transmembrane transport of small molecules—ALB—Crohn's disease	9e-06	0.000351	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	8.99e-06	0.00035	CbGpPWpGaD
Nicotine—SLC22A5—Transmembrane transport of small molecules—ALB—Crohn's disease	8.97e-06	0.000349	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—MTMR3—Crohn's disease	8.73e-06	0.00034	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PLA2G4F—Crohn's disease	8.69e-06	0.000339	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—GPX4—Crohn's disease	8.6e-06	0.000335	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—FADS1—Crohn's disease	8.56e-06	0.000334	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—MTMR3—Crohn's disease	8.55e-06	0.000333	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—FADS1—Crohn's disease	8.43e-06	0.000329	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	8.42e-06	0.000328	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—GCKR—Crohn's disease	8.3e-06	0.000324	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—MTMR3—Crohn's disease	8.06e-06	0.000314	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—GPX4—Crohn's disease	8.01e-06	0.000312	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—PTGS2—Crohn's disease	7.91e-06	0.000308	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—GPX4—Crohn's disease	7.89e-06	0.000308	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PLA2G4F—Crohn's disease	7.76e-06	0.000302	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—GCKR—Crohn's disease	7.74e-06	0.000302	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—GCKR—Crohn's disease	7.62e-06	0.000297	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—MTMR3—Crohn's disease	7.39e-06	0.000288	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	7.14e-06	0.000278	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	7.07e-06	0.000276	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	6.84e-06	0.000267	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—FADS1—Crohn's disease	6.8e-06	0.000265	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—FADS1—Crohn's disease	6.66e-06	0.00026	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—MTMR3—Crohn's disease	6.6e-06	0.000257	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—GPX4—Crohn's disease	6.37e-06	0.000248	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—FADS1—Crohn's disease	6.28e-06	0.000245	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—GPX4—Crohn's disease	6.24e-06	0.000243	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—GCKR—Crohn's disease	6.15e-06	0.00024	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—MTMR3—Crohn's disease	6.07e-06	0.000236	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PLA2G4F—Crohn's disease	6.05e-06	0.000236	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—GCKR—Crohn's disease	6.02e-06	0.000235	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—MTMR3—Crohn's disease	6.02e-06	0.000234	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	5.99e-06	0.000233	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—GPX4—Crohn's disease	5.88e-06	0.000229	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—FADS1—Crohn's disease	5.76e-06	0.000224	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—GCKR—Crohn's disease	5.68e-06	0.000221	CbGpPWpGaD
Nicotine—SLC22A2—Transmembrane transport of small molecules—ALB—Crohn's disease	5.64e-06	0.00022	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—GPX4—Crohn's disease	5.39e-06	0.00021	CbGpPWpGaD
Nicotine—SLC22A1—Transmembrane transport of small molecules—ALB—Crohn's disease	5.26e-06	0.000205	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—GCKR—Crohn's disease	5.21e-06	0.000203	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—MTMR3—Crohn's disease	5.14e-06	0.0002	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—FADS1—Crohn's disease	5.14e-06	0.0002	CbGpPWpGaD
Nicotine—MAOB—Metabolism—ALB—Crohn's disease	4.98e-06	0.000194	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—GPX4—Crohn's disease	4.81e-06	0.000188	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—FADS1—Crohn's disease	4.73e-06	0.000184	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—FADS1—Crohn's disease	4.69e-06	0.000183	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	4.67e-06	0.000182	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—GCKR—Crohn's disease	4.65e-06	0.000181	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—GPX4—Crohn's disease	4.43e-06	0.000173	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—GPX4—Crohn's disease	4.39e-06	0.000171	CbGpPWpGaD
Nicotine—MAOB—Metabolism—PTGS2—Crohn's disease	4.36e-06	0.00017	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—GCKR—Crohn's disease	4.28e-06	0.000167	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—GCKR—Crohn's disease	4.24e-06	0.000165	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—ALB—Crohn's disease	4.21e-06	0.000164	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	4.06e-06	0.000158	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—FADS1—Crohn's disease	4e-06	0.000156	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—MTMR3—Crohn's disease	3.97e-06	0.000155	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—GPX4—Crohn's disease	3.75e-06	0.000146	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.72e-06	0.000145	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—PTGS2—Crohn's disease	3.69e-06	0.000144	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—GCKR—Crohn's disease	3.62e-06	0.000141	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.55e-06	0.000138	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.32e-06	0.000129	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.26e-06	0.000127	CbGpPWpGaD
Nicotine—MAOA—Metabolism—ALB—Crohn's disease	3.13e-06	0.000122	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—FADS1—Crohn's disease	3.09e-06	0.00012	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—ALB—Crohn's disease	3.05e-06	0.000119	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.03e-06	0.000118	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.91e-06	0.000113	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—GPX4—Crohn's disease	2.89e-06	0.000113	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—GCKR—Crohn's disease	2.8e-06	0.000109	CbGpPWpGaD
Nicotine—MAOA—Metabolism—PTGS2—Crohn's disease	2.73e-06	0.000107	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—PTGS2—Crohn's disease	2.67e-06	0.000104	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.65e-06	0.000103	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—ALB—Crohn's disease	2.64e-06	0.000103	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.59e-06	0.000101	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—ALB—Crohn's disease	2.46e-06	9.6e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—ALB—Crohn's disease	2.43e-06	9.46e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PTGS2—Crohn's disease	2.31e-06	9.01e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.26e-06	8.82e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PTGS2—Crohn's disease	2.16e-06	8.4e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PTGS2—Crohn's disease	2.12e-06	8.27e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—ALB—Crohn's disease	1.96e-06	7.63e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—ALB—Crohn's disease	1.92e-06	7.47e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—ALB—Crohn's disease	1.81e-06	7.04e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PTGS2—Crohn's disease	1.71e-06	6.67e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PTGS2—Crohn's disease	1.68e-06	6.54e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—ALB—Crohn's disease	1.66e-06	6.46e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PTGS2—Crohn's disease	1.58e-06	6.16e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—ALB—Crohn's disease	1.48e-06	5.76e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PTGS2—Crohn's disease	1.45e-06	5.65e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—ALB—Crohn's disease	1.36e-06	5.3e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—ALB—Crohn's disease	1.35e-06	5.26e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PTGS2—Crohn's disease	1.29e-06	5.04e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PTGS2—Crohn's disease	1.19e-06	4.64e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PTGS2—Crohn's disease	1.18e-06	4.6e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—ALB—Crohn's disease	1.15e-06	4.49e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PTGS2—Crohn's disease	1.01e-06	3.93e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—ALB—Crohn's disease	8.9e-07	3.47e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PTGS2—Crohn's disease	7.78e-07	3.03e-05	CbGpPWpGaD
